References
- following Epo induced receptor tyrosine phosphorylation: identification of potential binding sites. Stood 1994; 85: 87–95
- Klingmuller U, Lorenz U, Cantley L C, Neel B G, Lodish H F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signaling. Cell 1995; 80: 729–38
- Dong F, Hoefsloot L H, Schelen A M, et al. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 1994; 91: 4480–4
- Fukunaga R, Ishizaka-Lkeda E, Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell 1993; 74: 1079–87
- Duquesnoy R, Sobrier M-L, Duriez B, et al. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J 1994; 13: 1386–95
- Shtivelman E, Lifshifz B, Gale R P, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–4
- Kurzrock R, Gutterman J U, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990–8
- Pendergast A M, Quilliam L A, Cripe L D, et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of GRB-2 adaptor protein. Cell 1993; 75: 175–85
- Danial N N, Pernis A, Rothman P B. Jak-STAT signaling induced by the v-abl oncogene. Science 1995; 269: 1875–7
- Gonda T J, D'Andrea R J. Activating mutations in cytokine receptors: implications for receptor function and role in disease. Blood 1997; 89: 355–69
- Meydan N, Grunberger T, Dadi H, et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379: 645–8
- Friedrich W. Bone marrow transplantation in immunodeficiency diseases. Ann Med 1996; 28: 115–9
- Blaese R M. Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res 1993; 33: 49–53
- Brenner M K. Gene transfer in haematological malignancy. Ann Med 1996; 28: 491–7
- Elwood N J, Zogos H, Willson T, Begley C G. Retroviral transfer of human progenitor cells: use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro. Blood 1996; 88: 4452–62
- Taylor N, Uribe L, Smith S, Jahn T, Kohn D B, Weinberg K. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the yc gene. Blood 1996; 87: 3103–7